Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Medical authorities said late Friday that the young male patient was admitted to an isolated emergency ward at a hospital in Enkoping, northwest of Stockholm, with symptoms including blood in his vomit and stools. Officials said the condition of the man, who had spent several weeks in Burundi, improved over the course of the day. Tests also showed the man isn’t suffering from yellow fever, dengue, Marburg virus or Rift Valley fever either. All major Ebola outbreaks have been in Africa, though isolated cases have been reported outside the continent. Claim: Sweden: No Ebola virus detected in hospital patient.
Swedish health officials say a suspected Ebola case reported by a hospital has turned out to be a false alarm with tests carried out on the unidentified patient showing no signs of the deadly virus.

Paragraph: The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Teva said the money will come from a pre-existing fund that was created in 2015 as part of the company’s settlement with the U.S. Federal Trade Commission over similar claims, and it will not make any additional payments. Becerra said such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. “No one in America should be forced to skip or ration doses of medicine that they need ... and certainly not because a drug company is colluding to keep the price of your drug artificially high even when cheaper options could be available. But that’s what’s happening,” Becerra said. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Teva said it is paying $200,000 to cover the state’s legal costs after settling similar federal claims earlier this year. Neither Endo nor Teikoku responded to requests for comment. Both settlements bar the companies from pay-for-delay agreements for several years. Teva is agreeing to not to enter any such agreements for 10 years, while Endo Pharmaceuticals has an eight-year agreement and Teikoku a 20-year injunction. Teva said the restriction is identical to its federal consent decree. Becerra also backed pending legislation, AB824 by Democratic Assemblyman Jim Wood of Santa Rosa, that would ban such agreements. The measure would require pharmaceutical companies to prove that their agreements are not anticompetitive. It passed the Assembly 56-0 in May and is awaiting a vote in the Senate. Pharmaceutical companies oppose the bill, arguing the Federal Trade Commission already does this monitoring. ___ This story has been corrected to say that while there are four settlement agreements, they involve only three companies. Claim: 3 companies pay California $70 million for delaying drugs.
Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday.

Paragraph: Kentaro Iwata, a professor of infectious disease at Kobe University, said on his blog on Thursday that it’s not clear that the outbreak in Japan will have subsided by the planned start of the Games in July. Also, the flood of foreign visitors could exacerbate the spread of the disease, known as COVID-19. Japanese government officials have said the Olympics will go ahead as scheduled and will not be held behind closed doors. “The Olympics are not just a mass gathering, but a mass gathering from all over the world, while COVID is a global pandemic,” Iwata wrote. “These two things don’t go together.”  Iwata boarded the quarantined Diamond Princess cruise ship in February and his YouTube videos decrying the conditions there garnered more than a million views. Iwata said that bureaucrats, and not infectious disease professionals, were running the quarantine, and that basic protocols on zoning and the use of protective gear were not followed. Japan has recorded more than 1,600 cases of the virus, including about 700 from the Diamond Princess. Thirty nine people have died, including seven from the liner. The virus has spread around the world, with more than 218,000 confirmed cases and 8,900 deaths. Claim: Diamond Princess critic says Tokyo Olympics should be halted.

The Japanese doctor who created a media firestorm with videos criticizing the quarantine of a coronavirus-stricken cruise ship said he now believes the Tokyo 2020 Olympics should not go on.